| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |